Integrated Wealth Concepts LLC Erasca, Inc. Transaction History

Integrated Wealth Concepts LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.67 - $2.49 $33,400 - $49,800	-20,000 Reduced 64.52%	11,000 $23,000
Q3 2023 Nov 15, 2023	BUY	$1.97 - $2.91 $19,463 - $28,750	9,880 Added 46.78%	31,000 $61,000
Q2 2023 Aug 15, 2023	BUY	$2.57 - $3.3 $308 - $396	120 Added 0.57%	21,120 $58,000
Q1 2023 May 03, 2023	BUY	$2.74 - $4.44 $57,540 - $93,240	21,000 New	21,000 $63,000

141

229M

28.7K

117K

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $333M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Wealth Concepts LLC with notifications on news.